{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:12:55Z","timestamp":1791987175794,"version":"4.4.0"},"reference-count":28,"publisher":"Massachusetts Medical Society","issue":"10","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["12-219"],"award-info":[{"award-number":["12-219"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2022,3,10]]},"DOI":"10.1056\/nejmoa2111953","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T17:01:35Z","timestamp":1646845295000},"page":"923-932","source":"Crossref","is-referenced-by-count":223,"title":["Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer"],"prefix":"10.1056","volume":"386","author":[{"given":"Sophie","family":"Leboulleux","sequence":"first","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bournaud","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile N.","family":"Chougnet","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slimane","family":"Zerdoud","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Al Ghuzlan","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Catargi","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Kelly","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Luce","family":"Barge","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lacroix","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Dygai","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vera","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rusu","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Schneegans","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Benisvy","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Klein","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Roux","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Eberle","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bastie","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Nascimento","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Giraudet","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Le Moullec","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bardet","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Roudaut","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Godbert","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Drutel","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Lamartina","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Schvartz","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz-Line","family":"Velayoudom","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Jean","family":"Schlumberger","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Leenhardt","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Borget","sequence":"additional","affiliation":[{"name":"From the Department of Nuclear Medicine and Endocrine Oncology (S.L., L. Lamartina, M.-J.S.), the Department of Medical Biology and Pathology (A.A.G., L. Lacroix), and the Biostatistics and Epidemiology Office, Oncostat, INSERM Unit\u00e9 1018 (I.B.), Gustave Roussy and Universit\u00e9 Paris-Saclay, Villejuif, the Nuclear Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron (C.B.), the Endocrine Oncology Department, Assistance Publique\u2013H\u00f4pitaux de Paris (AP\u2013HP) H\u00f4pital Saint-Louis (C.N.C.), and the Thyroid and Endocrine Tumors Unit, Piti\u00e9\u2013Salp\u00e9tri\u00e8re Hospital AP\u2013HP, Institute of Cancer IUC Sorbonne University (L. Leenhardt), Paris, the Department of Medical Imaging, Nuclear Medicine, IUCT Oncopole Toulouse\u2013Institut Claudius Regaud (S.Z.), and the Nuclear Medicine Department, CHU Rangueil (D. Bastie), Toulouse, the Department of Endocrinology\u2013Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Centre Hospitalier Universitaire (CHU) de Bordeaux (B.C.), and the Thyroid Oncology and Nuclear Medicine Depar..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1604412"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2719"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0299"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109589"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108586"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30113-X"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30306-1"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04479-1"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2008.02.007"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-1346"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02158"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0110"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.02.009"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3882"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","unstructured":"Brierley JD Gospodarowicz MK Wittekind C eds. TNM classification of malignant tumours. 8th ed. Oxford United Kingdom: Wiley Blackwell 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0386"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2020.11.006"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0104"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2014.1"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1123"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-014-9345-4"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02531-x"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0582"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.8253"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00431"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3401"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0128"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2111953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:19:22Z","timestamp":1749669562000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2111953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,3,10]]}},"alternative-id":["10.1056\/NEJMoa2111953"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2111953","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741801708.793594739","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.741801708.793592320","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.741801708.793593207","asserted-by":"object"}]},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}